Biovara approves share capital split prior to fund raising

12 June, 2025|

The issued share capital of Biovara has been increased to 8 million ordinary shares.

Related news

Professor Jaclyn Smith – regarded as world leading expert on chronic cough, including Lung Cancer Cough, endorses Biovara’s clinical approach

ACF Research publication of independent thematic research note on Lung Cancer Cough market

Biovara adopts ESG policy